8,024 companies listed on NYSE, Nasdaq and the OTC markets. Financials come straight from their SEC filings.
Prices as of the close on Oct 19, 2026
How US stocks on Nasdaq moved on Oct 19, 2026
3,443 companies
| Market cap |
|---|
| Revenue |
|---|
| Net margin |
|---|
| P/E |
|---|
| 2301 | $75.34 | +2.18% | −1.19% | −22.52% | $6.21B | $1.93B | 8.2% | 39.0 | ||
| 2302 | $25.72 | +0.86% | −21.06% | −34.10% | $6.23B | $5.25B | 12.3% | 9.7 | ||
| 2303 | $234.94 | +1.94% | +59.82% | +58.19% | $6.26B | $4.03B | 4.6% | 33.8 | ||
| 2304 | $46.33 | −0.77% | +20.65% | +31.51% | $6.31B | $1.28B | 40.2% | 12.3 | ||
| 2305 | $152.79 | +2.47% | +21.88% | −11.12% | $6.33B | $1.22B | 5.6% | 92.7 | ||
| 2306 | $46.18 | −0.22% | +16.50% | +29.97% | $6.35B | $1.25B | – | – | ||
| 2307 | $31.49 | −1.13% | +43.66% | +32.65% | $6.42B | $1.93B | 12.3% | 27.0 | ||
| 2308 | $16.99 | +1.01% | −12.29% | −13.01% | $6.43B | $6.77B | 42.3% | 2.2 | ||
| 2309 | $99.92 | +0.22% | +50.14% | +79.71% | $6.52B | $1.56B | 17.7% | 23.7 | ||
| 2310 | $190.08 | +4.99% | +43.02% | +50.14% | $6.58B | $702.98M | 29.4% | 31.8 | ||
| 2311 | $78.20 | +3.48% | +124.3% | +145.0% | $6.61B | $595.97M | −9.6% | – | ||
| 2312 | $107.71 | −0.82% | +70.72% | +64.89% | $6.62B | $1.56B | 29.6% | 14.4 | ||
| 2313 | $142.11 | +0.25% | −19.03% | −56.14% | $6.65B | $1.15B | 35.9% | 16.2 | ||
| 2314 | $25.67 | +1.14% | +50.29% | – | $6.68B | $825.87M | −42.1% | – | ||
| 2315 | $56.30 | −1.50% | +33.16% | +26.33% | $6.79B | $157.71B | 0.3% | 12.9 | ||
| 2316 | $28.53 | −3.06% | −26.83% | −23.63% | $6.79B | $18.44B | 3.0% | 12.5 | ||
| 2317 | $12.57 | −0.71% | +7.62% | +28.27% | $6.95B | $2.15B | 32.2% | 10.0 | ||
| 2318 | $77.11 | +8.12% | +342.4% | +354.4% | $6.99B | $568.93M | −18.2% | – | ||
| 2319 | $31.82 | −0.19% | −53.36% | −54.43% | $7.16B | $2.81B | 2.0% | 130.1 | ||
| 2320 | $18.27 | −1.98% | −18.18% | −17.67% | $7.19B | $15.47B | 6.8% | 6.8 | ||
| 2321 | $42.97 | +4.25% | +53.57% | +42.00% | $7.21B | $1.67B | 4.0% | 109.0 | ||
| 2322 | $260.17 | +7.61% | −11.73% | +36.94% | $7.26B | $0 | – | – | ||
| 2323 | $39.17 | −3.09% | −48.40% | −52.88% | $7.35B | $1.52B | 2.0% | 238.0 | ||
| 2324 | $220.99 | −0.00% | +69.08% | +62.36% | $7.37B | $855.89M | −4.6% | – | ||
| 2325 | $44.38 | +3.35% | −43.90% | −39.28% | $7.38B | $874.09M | −64.7% | – | ||
| 2326 | $86.83 | +0.30% | +15.37% | +29.81% | $7.44B | $6.47B | 8.8% | 13.1 | ||
| 2327 | $78.26 | +4.37% | −26.52% | −15.39% | $7.47B | $1.06B | −12.1% | – | ||
| 2328 | $122.86 | −1.58% | +3.71% | +14.01% | $7.47B | $2.28B | 28.5% | 11.5 | ||
| 2329 | syreSpyre Therapeutics | $84.72 | +6.03% | +158.6% | +277.0% | $7.47B | $0 | – | – | |
| 2330 | $211.91 | −0.10% | −8.91% | −10.02% | $7.51B | $1.04B | 15.1% | 47.6 | ||
| 2331 | $29.72 | +5.43% | −35.02% | −54.18% | $7.52B | $3.05B | 4.2% | 58.2 | ||
| 2332 | $91.88 | +2.05% | +91.10% | +76.42% | $7.54B | $27.63B | 1.2% | 22.6 | ||
| 2333 | $33.22 | −0.18% | −5.09% | −16.64% | $7.56B | $5.37B | −3.1% | – | ||
| 2334 | $93.07 | +1.13% | +1.59% | +1.76% | $7.70B | $1.36B | 17.4% | 32.6 | ||
| 2335 | $205.66 | −0.82% | −5.36% | −4.13% | $7.72B | $2.57B | – | – | ||
| 2336 | $11.68 | −1.68% | −23.81% | −1.52% | $7.73B | $58.34B | −0.6% | – | ||
| 2337 | $32.40 | −3.05% | +34.33% | +63.64% | $7.76B | – | – | – | ||
| 2338 | $75.98 | +0.50% | −36.86% | −35.51% | $7.82B | $7.41B | 6.1% | 17.4 | ||
| 2339 | $19.42 | +2.21% | +10.72% | −12.68% | $7.93B | $802.64M | −91.8% | – | ||
| 2340 | $55.69 | +0.23% | +6.40% | +11.59% | $7.99B | $449.36M | – | 13.7 | ||
| 2341 | $28.33 | −0.39% | +1.36% | +16.49% | $8.01B | $2.65B | 26.8% | 11.3 | ||
| 2342 | $57.23 | +2.38% | −13.80% | +55.47% | $8.08B | $669.50M | −47.8% | – | ||
| 2343 | $35.94 | +1.04% | +29.28% | +23.48% | $8.11B | $2.53B | 17.5% | 18.3 | ||
| 2344 | $53.30 | −1.24% | +78.80% | +53.74% | $8.16B | $799.54M | 55.2% | 18.5 | ||
| 2345 | $155.81 | −0.85% | −14.69% | +21.78% | $8.16B | $776.57M | −24.7% | – | ||
| 2346 | $60.29 | +2.48% | +74.96% | +68.93% | $8.31B | $4.63B | −0.6% | – | ||
| 2347 | $322.40 | +0.97% | +1.26% | −12.12% | $8.32B | $788.50M | 38.3% | 27.5 | ||
| 2348 | $68.17 | +0.62% | +48.39% | +40.67% | $8.40B | $317.95M | −188.6% | – | ||
| 2349 | $154.48 | −0.05% | +66.65% | +72.14% | $8.45B | $6.32B | 13.4% | 10.0 | ||
| 2350 | $55.37 | +1.04% | +17.53% | +49.73% | $8.59B | $3.50B | −2.0% | – |